Showing 1631-1640 of 10610 results for "".
Incorporating Guideline-Recommended Targeted Therapies Into R/R AML Management
https://reachmd.com/programs/cme/incorporating-guideline-recommended-targeted-therapies-into-rr-aml-management/36181/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.Molecular Profiling as a Cornerstone of Precision AML Therapy
https://reachmd.com/programs/cme/molecular-profiling-as-a-cornerstone-of-precision-aml-therapy/36178/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.Stratifying Risk to Guide Therapy in R/R AML
https://reachmd.com/programs/cme/stratifying-risk-to-guide-therapy-in-rr-aml/36177/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.Menin Inhibitors: Biologic and Clinical Rationale
https://reachmd.com/programs/cme/menin-inhibitors-biologic-and-clinical-rationale/36179/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.Expert Recommendations and Key Takeaways
https://reachmd.com/programs/cme/expert-recommendations-and-key-takeaways/36186/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.Clinical Evidence on Monotherapy With Menin Inhibitors in R/R AML
https://reachmd.com/programs/cme/clinical-evidence-on-monotherapy-with-menin-inhibitors-in-rr-aml/36180/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.Using Nerve Blocks to Avoid Pain and Narcotics for Rhinoplasty
https://reachmd.com/topics/surgical/using-nerve-blocks-to-avoid-pain-and-narcotics-for-rhinoplasty/35422/A Q&A with Anil R. Shah, MD, FACSPractical Perspectives in Myasthenia Gravis #3: Therapeutic Selection and Monitoring Efficacy—Matching Mechanisms to Patients
https://reachmd.com/programs/cme/mg-therapeutic-selection-and-monitoring-efficacy-matching-mechanisms-to-patients/39030/Examine evolving gMG management, from standard therapies to targeted agents, with an emphasis on pediatric care and assessment of treatment response.Women’s Sleep Health – Addressing Gaps in OSA Diagnosis and Treatment Across Life Stages
https://reachmd.com/programs/cme/womens-sleep-health-addressing-gaps-in-osa-diagnosis-and-treatment-across-life-stages/36099/Explore women’s life stage–specific factors in OSA diagnosis and management to improve sleep and cardiometabolic outcomes.Clearing the Brain Fog: Innovations in the Treatment and Management of Hepatic Encephalopathy
https://reachmd.com/programs/cme/Clearing-the-Brain-Fog-Innovations-in-the-Treatment-and-Management-of-Hepatic-Encephalopathy/39047/Explore diagnostic and treatment challenges in patients with hepatic encephalopathy to improve outcomes for your patients.